branded drugs
Trump Administration Drops Plans to Impose Tariffs on Generic Drugs: A Positive Development for Indian Pharmaceutical Industry
Oct 10, 2025 06:25 pm CST
The Trump administration has decided against implementing tariffs on generic drugs imported from foreign countries, providing relief to both Indian pharmaceutical manufacturers, who supply nearly half of all generic prescriptions in the US market, and American consumers who depend on affordable medications. This decision comes after President Trump had previously announced 100 percent tariffs on branded drugs starting October 1.
Trump's 100% Pharmaceutical Tariffs: Global Impact on Countries and Companies
Sep 26, 2025 10:59 pm CST
President Trump's announcement of 100% tariffs on imported branded pharmaceuticals has sent shockwaves through the global drug industry. This policy, set to take effect in five days unless companies begin constructing US manufacturing facilities, threatens international pharmaceutical trade worth $252 billion annually. While the European Union claims protection through an existing trade agreement, countries like Switzerland and Denmark face significant risks. Pharmaceutical giants have already pledged $300 million in US investments as companies scramble to adapt to this protectionist measure that exempts generic medications but targets patented drugs.